Once an outpost of Boies, Schiller & Flexner, four-year-old Stone & Magnanini is making a name for itself as a go-to shop for health care qui tam suits under the False Claims Act. Conflicts with Boies Schiller’s pharmaceutical and health care clients led David Stone and Robert Magnanini to go out on their own in 2009, and last year they reaped the dividends.
Those included a $360 million settlement in July from McKesson Corp., the nation’s largest pharmaceutical wholesaler, in a major case joined by the U.S. Department of Justice. The suit began in 2004 after a pharmacy auditor uncovered evidence the company was manipulating a key price index used to determine the cost of prescription drugs sold to government health care programs.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
